Consultant Obligations. A. Consultant represents, warrants and covenants his/her collection, access, use, storage, disposal and disclosure of any Personal Information does and will comply with all applicable privacy and data protection laws. B. Consultant shall process Personal Information in accordance with ▇▇▇▇▇’▇ written instructions and only as necessary to carry out its obligations pursuant to this Agreement, or as required by applicable law. C. Consultant shall take reasonable and appropriate measures to protect Personal Information from loss, misuse and unauthorized access, disclosure, alteration and destruction. D. In the event that Consultant discloses Personal Information to a third party, Consultant shall enter into an agreement with such third parties that includes terms consistent with the terms of this Addendum. E. Consultant will notify ▇▇▇▇▇ as soon as practicable, but no later than twenty-four (24) hours after Consultant becomes aware that the security, confidentiality or integrity of Personal Information has been compromised and Consultant will fully cooperate with ▇▇▇▇▇ to comply with any obligations that arise from the unauthorized access of the Personal Information. F. In the event that Consultant receives an access request, inquiry or complaint from the data subject, Consultant shall not respond without, and then only in accordance with, the prior written approval of ▇▇▇▇▇, unless required by applicable law. Consultant shall promptly carry out any request from ▇▇▇▇▇ to amend, transfer, or delete, or to provide ▇▇▇▇▇ with a copy of the Personal Information, in whole or in part. G. When Personal Information collected by Consultant under the terms of this Agreement is no longer necessary for the performance of Services under this Agreement, Consultant shall securely destroy or, at ▇▇▇▇▇’▇ written request, return to ▇▇▇▇▇ or its designee, all Personal Information in Consultant’s possession, custody or control, unless prohibited by applicable law. H. Consultant shall notify ▇▇▇▇▇ if it determines that it can no longer meet its obligations under this Addendum and, at ▇▇▇▇▇’▇ direction, cease processing Personal Information. I. Consultant shall comply with the terms of this Addendum for as long as it is in possession of Personal Information.
Appears in 5 contracts
Sources: Consulting Agreement (Spero Therapeutics, Inc.), Consulting Agreement (Spero Therapeutics, Inc.), Consulting Agreement (Spero Therapeutics, Inc.)
Consultant Obligations. A. Consultant represents, warrants and covenants his/her collection, access, use, storage, disposal and disclosure of any Personal Information does and will comply with all applicable privacy and data protection laws.
B. Consultant shall process Personal Information in accordance with ▇S▇▇▇▇’▇ written instructions and only as necessary to carry out its obligations pursuant to this Agreement, or as required by applicable law.
C. Consultant shall take reasonable and appropriate measures to protect Personal Information from loss, misuse and unauthorized access, disclosure, alteration and destruction.
D. In the event that Consultant discloses Personal Information to a third party, Consultant shall enter into an agreement with such third parties that includes terms consistent with the terms of this Addendum.
E. Consultant will notify ▇S▇▇▇▇ as soon as practicable, but no later than twenty-four (24) hours after Consultant becomes aware that the security, confidentiality or integrity of Personal Information has been compromised and Consultant will fully cooperate with ▇S▇▇▇▇ to comply with any obligations that arise from the unauthorized access of the Personal Information.
F. In the event that Consultant receives an access request, inquiry or complaint from the data subject, Consultant shall not respond without, and then only in accordance with, the prior written approval of ▇S▇▇▇▇, unless required by applicable law. Consultant shall promptly carry out any request from ▇S▇▇▇▇ to amend, transfer, or delete, or to provide ▇S▇▇▇▇ with a copy of the Personal Information, in whole or in part.
G. When Personal Information collected by Consultant under the terms of this Agreement is no longer necessary for the performance of Services under this Agreement, Consultant shall securely destroy or, at ▇S▇▇▇▇’▇ written request, return to ▇S▇▇▇▇ or its designee, all Personal Information in Consultant’s possession, custody or control, unless prohibited by applicable law.
H. Consultant shall notify ▇S▇▇▇▇ if it determines that it can no longer meet its obligations under this Addendum and, at ▇S▇▇▇▇’▇ direction, cease processing Personal Information.
I. Consultant shall comply with the terms of this Addendum for as long as it is in possession of Personal Information.
Appears in 3 contracts
Sources: Consulting Agreement (Spero Therapeutics, Inc.), Consulting Agreement (Spero Therapeutics, Inc.), Consulting Agreement (Spero Therapeutics, Inc.)
Consultant Obligations. A. i. Consultant represents, warrants and covenants his/her collection, access, use, storage, disposal and disclosure of any Personal Information does and will comply with all applicable privacy and data protection laws.
B. ii. Consultant shall process Personal Information in accordance with ▇▇▇▇▇’▇ the LogicBio’s written instructions and only as necessary to carry out its his or her obligations pursuant to this Agreement, or as required by applicable law.
C. iii. Consultant shall take reasonable and appropriate measures to protect Personal Information from loss, misuse and unauthorized access, disclosure, alteration and destruction.
D. iv. In the event that Consultant discloses Personal Information to a third party, Consultant shall enter into an agreement with such third parties that includes terms consistent with the terms of this Addendum.
E. v. Consultant will notify ▇▇▇▇▇ the LogicBio as soon as practicable, but no later than twenty-four (24) hours after Consultant becomes aware that the security, confidentiality or integrity of Personal Information has been compromised and Consultant will fully cooperate with ▇▇▇▇▇ the LogicBio to comply with any obligations that arise from the unauthorized access of the Personal Information.
F. vi. In the event that Consultant receives an access request, inquiry or complaint from the data subject, Consultant shall not respond without, and then only in accordance with, the prior written approval of ▇▇▇▇▇the LogicBio, unless required by applicable law. Consultant shall promptly carry out any request from ▇▇▇▇▇ the LogicBio to amend, transfer, or delete, or to provide ▇▇▇▇▇ the LogicBio with a copy of the Personal Information, in whole or in part.
G. vii. When Personal Information collected by Consultant under the terms of this Agreement contract is no longer necessary for the performance of Services services under this Agreementcontract, Consultant shall securely destroy or, at ▇▇▇▇▇’▇ the LogicBio’s written request, return to ▇▇▇▇▇ the LogicBio or its designee, designee all Personal Information in Consultant’s possession, custody or control, unless prohibited by applicable law.
H. viii. Consultant shall notify ▇▇▇▇▇ the LogicBio if it determines that it he or she can no longer meet its his or her obligations under this Addendum Article 8 and, at ▇▇▇▇▇’▇ the LogicBio’s direction, cease processing Personal Information.
I. ix. Consultant shall comply with the terms of this Addendum Article 8 for as long as it he/she is in possession of Personal Information.
Appears in 1 contract
Sources: Consultancy Agreement (LogicBio Therapeutics, Inc.)
Consultant Obligations. A. i. Consultant represents, warrants and covenants his/her collection, access, use, storage, disposal and disclosure of any Personal Information does and will comply with all applicable privacy and data protection laws.
B. ii. Consultant shall process Personal Information in accordance with ▇▇▇▇▇’▇ the LogicBio’s written instructions and only as necessary to carry out its his or her obligations pursuant to this Agreement, or as required by applicable law.
C. iii. Consultant shall take reasonable and appropriate measures to protect Personal Information from loss, misuse and unauthorized access, disclosure, alteration and destruction.
D. iv. In the event that Consultant discloses Personal Information to a third party, Consultant shall enter into an agreement with such third parties that includes terms consistent with the terms of this Addendum.
E. v. Consultant will notify ▇▇▇▇▇ the LogicBio as soon as practicable, but no later than twenty-four (24four(24) hours after Consultant becomes aware that the security, confidentiality or integrity of Personal Information has been compromised and Consultant will fully cooperate with ▇▇▇▇▇ the LogicBio to comply with any obligations that arise from the unauthorized access of the Personal Information.
F. vi. In the event that Consultant receives an access request, inquiry or complaint from the data subject, Consultant shall not respond without, and then only in accordance with, the prior written approval of ▇▇▇▇▇the LogicBio, unless required by applicable law. Consultant shall promptly carry out any request from ▇▇▇▇▇ the LogicBio to amend, transfer, or delete, or to provide ▇▇▇▇▇ the LogicBio with a copy of the Personal Information, in whole or in part.
G. vii. When Personal Information collected by Consultant under the terms of this Agreement contract is no longer necessary for the performance of Services services under this Agreementcontract, Consultant shall securely destroy or, at ▇▇▇▇▇’▇ the LogicBio’s written request, return to ▇▇▇▇▇ the LogicBio or its designee, designee all Personal Information in Consultant’s possession, custody or control, unless prohibited by applicable law.
H. viii. Consultant shall notify ▇▇▇▇▇ the LogicBio if it determines that it he or she can no longer meet its his or her obligations under this Addendum Article 8 and, at ▇▇▇▇▇’▇ the LogicBio’s direction, cease processing Personal Information.
I. ix. Consultant shall comply with the terms of this Addendum Article 8 for as long as it he/she is in possession of Personal Information.
Appears in 1 contract
Sources: Consultancy Agreement (LogicBio Therapeutics, Inc.)